These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
396 related articles for article (PubMed ID: 6314114)
1. Opiate receptor down-regulation and desensitization in neuroblastoma X glioma NG108-15 hybrid cells are two separate cellular adaptation processes. Law PY; Hom DS; Loh HH Mol Pharmacol; 1983 Nov; 24(3):413-24. PubMed ID: 6314114 [TBL] [Abstract][Full Text] [Related]
2. Ni-coupled receptors in cultured neural hybrid cells: cell specificity for dibutyryl cyclic AMP-induced down-regulation but not morphological differentiation. Noronha-Blob L; Lowe VC; Kinnier WJ; U'Prichard DC Mol Pharmacol; 1986 Dec; 30(6):526-36. PubMed ID: 3023808 [TBL] [Abstract][Full Text] [Related]
3. Loss of opiate receptor activity in neuroblastoma X glioma NG108-15 hybrid cells after chronic opiate treatment. A multiple-step process. Law PY; Hom DS; Loh HH Mol Pharmacol; 1982 Jul; 22(1):1-4. PubMed ID: 6126803 [TBL] [Abstract][Full Text] [Related]
4. Effect of chronic D-Ala,2 D-Leu5-enkephalin or pertussis toxin treatment on the high-affinity state of delta opioid receptor in neuroblastoma x glioma NG108-15 hybrid cells. Law PY; Hom DS; Loh HH J Pharmacol Exp Ther; 1991 Feb; 256(2):710-6. PubMed ID: 1847209 [TBL] [Abstract][Full Text] [Related]
5. Properties of delta opioid receptor in neuroblastoma NS20Y: receptor activation and neuroblastoma proliferation. Law PY; Bergsbaken C J Pharmacol Exp Ther; 1995 Jan; 272(1):322-32. PubMed ID: 7815347 [TBL] [Abstract][Full Text] [Related]
6. Multiple states of opioid receptors may modulate adenylate cyclase in intact neuroblastoma X glioma hybrid cells. Costa T; Wüster M; Gramsch C; Herz A Mol Pharmacol; 1985 Aug; 28(2):146-54. PubMed ID: 2991735 [TBL] [Abstract][Full Text] [Related]
7. Effects of cycloheximide and tunicamycin on opiate receptor activities in neuroblastoma X glioma NG108-15 hybrid cells. Law PY; Ungar HG; Hom DS; Loh HH Biochem Pharmacol; 1985 Jan; 34(1):9-17. PubMed ID: 2981531 [TBL] [Abstract][Full Text] [Related]
8. Sodium regulation of agonist binding at opioid receptors. I. Effects of sodium replacement on binding at mu- and delta-type receptors in 7315c and NG108-15 cells and cell membranes. Puttfarcken P; Werling LL; Brown SR; Cote TE; Cox BM Mol Pharmacol; 1986 Aug; 30(2):81-9. PubMed ID: 3016503 [TBL] [Abstract][Full Text] [Related]
9. Protein kinase C activation increases the rate and magnitude of agonist-induced delta-opioid receptor down-regulation in NG108-15 cells. Gucker S; Bidlack JM Mol Pharmacol; 1992 Oct; 42(4):656-65. PubMed ID: 1331757 [TBL] [Abstract][Full Text] [Related]
10. delta-Opioid receptor activates cAMP phosphodiesterase activities in neuroblastoma x glioma NG108-15 hybrid cells. Law PY; Loh HH Mol Pharmacol; 1993 May; 43(5):684-93. PubMed ID: 8388986 [TBL] [Abstract][Full Text] [Related]
11. Effect of forskolin and isobutylmethylxanthine on delta-opioid receptor activity in neuroblastoma x glioma NG108-15 cells. Bergsbaken CL; Sommers SL; Law PY J Pharmacol Exp Ther; 1993 Mar; 264(3):1474-83. PubMed ID: 7680718 [TBL] [Abstract][Full Text] [Related]
12. Heterologous up-regulation of Ni-coupled receptors in cultured neural hybrid cells by a transferable factor, whose expression is inhibited in a cyclic AMP-dependent, cell-specific manner. Noronha-Blob L; Lowe VC; Kinnier WJ; U'Prichard DC Mol Pharmacol; 1987 Nov; 32(5):669-77. PubMed ID: 2824982 [TBL] [Abstract][Full Text] [Related]
13. Potentiation of opiate action in neuroblastoma N18TG2 cells by lipid incorporation. Law PY; Nicksic TD; O'Rourke MA; Koehler JE; Herz A; Loh HH Mol Pharmacol; 1982 Mar; 21(2):492-502. PubMed ID: 6285174 [TBL] [Abstract][Full Text] [Related]
14. Muscarinic cholinergic receptors of two cell lines that regulate cyclic AMP metabolism by different molecular mechanisms. Evans T; Smith MM; Tanner LI; Harden TK Mol Pharmacol; 1984 Nov; 26(3):395-404. PubMed ID: 6092892 [TBL] [Abstract][Full Text] [Related]
15. Opiate regulation of adenosine 3':5'-cyclic monophosphate level in neuroblastoma X glioma NG108-15 hybrid cells. Relationship between receptor occupancy and effect. Law PY; Hom DS; Loh HH Mol Pharmacol; 1983 Jan; 23(1):26-35. PubMed ID: 6306425 [No Abstract] [Full Text] [Related]
16. Multiple opiate binding sites in the central nervous system of the rabbit. Large predominance of a mu subtype in the cerebellum and characterization of a kappa subtype in the thalamus. Meunier JC; Kouakou Y; Puget A; Moisand C Mol Pharmacol; 1983 Jul; 24(1):23-9. PubMed ID: 6306437 [TBL] [Abstract][Full Text] [Related]
17. Desensitization of catecholamine-stimulated adenylate cyclase and down-regulation of beta-adrenergic receptors in rat glioma C6 cells. Role of cyclic AMP and protein synthesis. Zaremba TG; Fishman PH Mol Pharmacol; 1984 Sep; 26(2):206-13. PubMed ID: 6207420 [TBL] [Abstract][Full Text] [Related]
18. Decrease in delta and mu opioid receptor binding capacity in rat brain after chronic etorphine treatment. Tao PL; Law PY; Loh HH J Pharmacol Exp Ther; 1987 Mar; 240(3):809-16. PubMed ID: 3031275 [TBL] [Abstract][Full Text] [Related]
19. Attenuation of opioid receptor activity by phorbol esters in neuroblastoma x glioma NG108-15 hybrid cells. Louie AK; Bass ES; Zhan J; Law PY; Loh HH J Pharmacol Exp Ther; 1990 Apr; 253(1):401-7. PubMed ID: 2158550 [TBL] [Abstract][Full Text] [Related]
20. Agonist-induced desensitization of D1-dopamine receptors linked to adenylyl cyclase activity in cultured NS20Y neuroblastoma cells. Barton AC; Sibley DR Mol Pharmacol; 1990 Oct; 38(4):531-41. PubMed ID: 1978240 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]